Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

3.19
Delayed Data
As of Nov 24
 0.00 / 0.00%
Today’s Change
2.01
Today|||52-Week Range
6.10
-37.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues3.3M2.6M3.4M4.7M
 
 
 
 
 
Cost of Goods Sold3.3M3.0M5.7M12.3M
 
 
 
 
 
Depreciation And Amortization117.9K118.1K277.1K836.1K
 
 
 
 
 
 
Operating ExpensesGross Income-77.2K-466.9K-2.6M-8.4M
 
 
 
 
 
General Expenses3.9M5.5M5.8M6.0M
 
 
 
 
 
Research And Development583.4K1.2M1.4M1.8M
 
 
 
 
 
Total Operating Expenses7.3M8.6M11.8M19.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-5.9M-8.4M-14.4M
 
 
 
 
 
Interest Expense On Debt628.2K618.5K642.5K783.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.6M-6.5M-9.0M-15.2M
 
 
 
 
 
Net Income-4.6M-6.5M-9.0M-15.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS----16.4M25.8M
 
 
 
Shares To Calculate EPS Diluted----16.4M25.8M
 
 
 
 
Earnings Per ShareEPS-$0.35-$0.51-$0.55-$0.59
 
 
 
 
 
EPS Diluted-----$0.55-$0.59